The evolution of L-dopa-induced dyskinesia in relation to L-dopa dose magnitude and frequency of administration

被引：0
|
作者：
Tsironis, C
Marselos, M
Konitsiotis, S
机构：
来源：
MOVEMENT DISORDERS | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S73 / S74
页数：2
相关论文
共 50 条
  • [41] L-dopa induced dyskinesia in Parkinson's disease
    Bastide, Matthieu F.
    Bezard, Erwan
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2015, 199 (2-3): : 201 - 212
  • [42] L-DOPA, dyskinesia and striatal plasticity
    Dunnett, S
    [J]. NATURE NEUROSCIENCE, 2003, 6 (05) : 437 - 438
  • [43] The role of opioid receptors in L-DOPA induced dyskinesia
    de Groote, C
    Brotchie, JM
    Crossman, AR
    [J]. BASAL GANGLIA VII, 2002, 52 : 43 - 52
  • [44] L-DOPA, dyskinesia and striatal plasticity
    Stephen Dunnett
    [J]. Nature Neuroscience, 2003, 6 : 437 - 438
  • [45] Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia
    Ghiglieri, Veronica
    Bagetta, Vincenza
    Pendolino, Valentina
    Picconi, Barbara
    Calabresi, Paolo
    [J]. PARKINSONS DISEASE, 2012, 2012
  • [46] Neuroinflammation in l-DOPA-induced dyskinesia: beyond the immune function
    Augusta Pisanu
    Laura Boi
    Giovanna Mulas
    Saturnino Spiga
    Sandro Fenu
    Anna R. Carta
    [J]. Journal of Neural Transmission, 2018, 125 : 1287 - 1297
  • [47] Nalbuphine Efficacy for L-Dopa-induced Dyskinesia in Parkinson Disease
    Mouradian, M. Maral
    Papa, Stella M.
    Voronkov, Michael
    Braithwaite, Steven P.
    [J]. NEUROTHERAPEUTICS, 2016, 13 (03) : 650 - 650
  • [48] Nociceptive Response to l-DOPA-Induced Dyskinesia in Hemiparkinsonian Rats
    G. C. Nascimento
    K. Bariotto-dos-Santos
    C. R. A. Leite-Panissi
    E. A. Del-Bel
    M. Bortolanza
    [J]. Neurotoxicity Research, 2018, 34 : 799 - 807
  • [49] Monoamine neurotransmission in the rat model of L-DOPA-induced dyskinesia
    Andersson, D.
    Lindgren, H. S.
    Lagerkvist, S.
    Cenci, M. A.
    Nissbrandt, H.
    [J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S143 - S143
  • [50] Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update
    AlShimemeri, Sohaila
    Fox, Susan H.
    Visanji, Naomi P.
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (02) : 131 - 144
12345